DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
GTS-21 is an investigational drug.
There have been 8 clinical trials for GTS-21. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2006.
The most common disease conditions in clinical trials are Tourette Syndrome, Syndrome, and Schizophrenia. The leading clinical trial sponsors are CoMentis, VA Office of Research and Development, and Radboud University.
Recent Clinical Trials for GTS-21
|Selective Microbiota Transplantation for Tourette's Syndrome||Faming Zhang||Phase 1/Phase 2|
|Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder||China Medical University Hospital||Phase 2|
|Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions||University of Florida||Phase 2|